Daewoong Pharmaceutical Co., Ltd (KRX:069620)
South Korea · Delayed Price · Currency is KRW 107,300
-4,300 (-3.85%)
At close: Jun 26, 2026
Daewoong Pharmaceutical Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, Daewoong Pharmaceutical stock has a consensus rating of "Buy" and an average price target of ₩206,667. The average 1-year stock price forecast is 92.61% higher than the current stock price, while the lowest is ₩200,000 (+86.39%) and the highest is ₩220,000 (+105.03%).
Price Target: ₩206,667 (+92.61%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Daewoong Pharmaceutical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 4 | 5 | 4 |
| Buy | 5 | 5 | 5 | 5 | 6 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 9 | 11 | 9 |
Financial Forecast
Revenue This Year
1.64T
from 1.57T
Increased by 4.55%
Revenue Next Year
1.81T
from 1.64T
Increased by 10.41%
EPS This Year
15.90K
from 14.45K
Increased by 10.01%
EPS Next Year
18.62K
from 15.90K
Increased by 17.14%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.7T | ||
| Avg | 1.6T | ||
| Low | 1.6T |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 7.8% | ||
| Avg | 4.6% | ||
| Low | 1.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 21,951.00 | ||
| Avg | 15,896.00 | ||
| Low | 12,222.00 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 51.9% | ||
| Avg | 10.0% | ||
| Low | -15.4% |